Safety and immunogenicity of COVID-19 mRNA vaccine SYS6006 evaluated in Phase 1 trial

Health News Comments Off on Safety and immunogenicity of COVID-19 mRNA vaccine SYS6006 evaluated in Phase 1 trial

Safety and immunogenicity of SYS6006 were evaluated in healthy adults after three doses of COVID-19 inactivated vaccines
Source: Read Full Article

Related posts:
  1. Home-visits before and after birth can benefit caregiving in low- and middle-income settings
  2. Brown fat: Implications in obesity
  3. Researchers find CXCR6 gene plays a role in COVID-19 severity
  4. High blood pressure: Unsalted tomato juice keeps the heart healthy and lowers reading
  5. New study shows mathematical models helped reduce the spread of COVID-19
  6. Is Prescribing Stimulants OK for Comorbid OUD, ADHD?
  7. 1 in 8 Americans over 50 show signs of ‘food addiction,’ poll finds